Table 5.
No. | Lipid Metabolism Regulators, (Pa) * | Reported Activity | Ref. |
---|---|---|---|
49 | Antihypercholesterolemic (0.914) Hypolipemic (0.635) |
Activity not studied | |
50 | Atherosclerosis treatment (0.911) Hypolipemic (0.836) Lipoprotein disorders treatment (0.826) Antihypercholesterolemic (0.802) |
Activity not studied | |
51 | Atherosclerosis treatment (0.907) Antihypercholesterolemic (0.788) |
Activity not studied | |
52 | Atherosclerosis treatment (0.919) Hypolipemic (0.822) Lipoprotein disorders treatment (0.814) |
Activity not studied | |
53 | Antihypercholesterolemic (0.926) Hypolipemic (0.800) Atherosclerosis treatment (0.709) |
Activity not studied | |
54 | Antihypercholesterolemic (0.900) Hypolipemic (0.827) Atherosclerosis treatment (0.659) Hyperparathyroidism treatment (0.502) |
Activity not studied | |
55 | Antihypercholesterolemic (0.917) Hypolipemic (0.786) |
Anticancer | [183] |
56 | Antihypercholesterolemic (0.917) Atherosclerosis treatment (0.858) Hypolipemic (0.786) |
Anticancer | [183] |
* Only activities with Pa > 0.5 are shown.